FDA
approval
· 2024-07-31
FDA Approved: VOQUEZNA DUAL PAK — Supplemental Application (Phathom Pharmaceuticals Inc.)
Summary
FDA approved a supplemental application for Voquezna Dual Pak, a combination of vonoprazan fumarate and amoxicillin, to treat Helicobacter pylori infection as p…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VOQUEZNA DUAL PAK (VONOPRAZAN FUMARATE AND AMOXICILLIN)